Rainbow Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.15 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.50 Cr
as on 16-11-2024
- Revenue 48.86%
(FY 2023)
- Profit 105.08%
(FY 2023)
- Ebitda 208.01%
(FY 2023)
- Net Worth 16.40%
(FY 2023)
- Total Assets 32.37%
(FY 2023)
About Rainbow Life Sciences
The Corporate was formerly known as Rainbow Life Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹8.15 Cr. The company has closed loans amounting to ₹5.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pramod Bharal and Prerana Gupta serve as directors at the Company.
- CIN/LLPIN
U24100MH1992PTC067886
- Company No.
067886
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rainbow Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Bharal  | Director | 27-Jul-1992 | Current |
| Prerana Gupta | Director | 30-Mar-2016 | Current |
Financial Performance of Rainbow Life Sciences.
Rainbow Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.86% increase. The company also saw a substantial improvement in profitability, with a 105.08% increase in profit. The company's net worth Soared by an impressive increase of 16.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rainbow Life Sciences?
In 2023, Rainbow Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Psa Chemicals And Pharmaceuticals Pvt LtdActive 32 years 3 monthsPramod Bharal and Prerana Gupta are mutual person
- Suman Pramod Bharal FoundationActive 2 years 5 months
Pramod Bharal and Prerana Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 03 Jul 2023 | ₹7.15 Cr | Open |
Standard Chartered Bank Creation Date: 03 Jul 2023 | ₹1.00 Cr | Open |
Citi Bank N.A. Creation Date: 17 May 2016 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Rainbow Life Sciences?
Rainbow Life Sciences has a workforce of 12 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rainbow Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rainbow Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
